West Pharmaceutical Services

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. 

CEO
Eric Mark Green
CEOEric Mark Green
Employees
10,800
Employees10,800
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1923
Founded1923
Employees
10,800
Employees10,800

WST Key Statistics

Market cap
22.35B
Market cap22.35B
Price-Earnings ratio
42.30
Price-Earnings ratio42.30
Dividend yield
0.27%
Dividend yield0.27%
Average volume
710.96K
Average volume710.96K
High today
$317.39
High today$317.39
Low today
$311.07
Low today$311.07
Open price
$313.33
Open price$313.33
Volume
531.03K
Volume531.03K
52 Week high
$330.88
52 Week high$330.88
52 Week low
$203.74
52 Week low$203.74

Stock Snapshot

West Pharmaceutical Services(WST) stock is priced at $316.42, giving the company a market capitalization of 22.35B. It carries a P/E multiple of 42.30 and pays a dividend yield of 27.5%.

On 2026-05-23, West Pharmaceutical Services(WST) stock moved within a range of $311.07 to $317.39. With shares now at $316.42, the stock is trading +1.7% above its intraday low and -0.3% below the session's peak.

Trading activity shows a volume of 531.03K, compared to an average daily volume of 710.96K.

Over the past 52 weeks, West Pharmaceutical Services(WST) stock has traded between a high of $330.88 and a low of $203.74.

Over the past 52 weeks, West Pharmaceutical Services(WST) stock has traded between a high of $330.88 and a low of $203.74.

WST News

MarketWatch 2d
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch

...

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Nasdaq 4d
DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany

DexCom DXCM recently announced the launch of Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for adults with Type 2 diabetes who are not...

DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany
Simply Wall St 5d
Does West Pharmaceutical Post-Cyberattack Rebound Quietly Reshape Its Higher-Margin Growth Story?

In early May 2026, West Pharmaceutical Services reported that shareholders voted against a proposal to require an independent board chair, while also outlining...

Does West Pharmaceutical Post-Cyberattack Rebound Quietly Reshape Its Higher-Margin Growth Story?

Analyst ratings

72%

of 18 ratings
Buy
72.2%
Hold
27.8%
Sell
0%

More WST News

Simply Wall St 6d
Is It Too Late To Consider West Pharmaceutical Services After Recent $1b Buyback Plan?

If you are wondering whether West Pharmaceutical Services at US$302.89 is still a sensible entry point or a stock to be cautious about, the valuation is the key...

Is It Too Late To Consider West Pharmaceutical Services After Recent $1b Buyback Plan?

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.